Overview of measures applied to designated persons according to the FAQ.

Restriction Impossible to be Registered: Lidings Team Defends Interests of Major Russian Pharmaceutical Manufacturer in Patent Dispute Over Registration of Generic.

Ministry of Economic Development published a Letter from 19.07.2022 No. 26614 – KM/D01i “On the elaboration of the Decree of the Russian President No. 322 from 27.05.2022” on its official website.

On 5 July 2022 the State Duma approved in the third reading a draft law No. 11662-8 “On amendments to art. 6 of the Federal Law “On trade secrets” and art. 45 of the Federal Law “On medicines circulation”, under which the Ministry of Industry and Trade will be granted access to trade secrets of medicines ьmanufacturing.

The Ministry of Industry and Trade partially legalized parallel import in Russia by approving the Decree No. 1532 of 19 April 2022 “On goods admissible for parallel import, that shall not be restricted by art. 1359(6) and 1487 of the Civil Code” . The list includes well-known brands of cars, home equipment, smartphones, etc.

On June 21, 2022 State Duma approved in the third hearing a draft law No. 127049-8 “On amendments to the article 18 of the Federal Law “On amendments to certain legislative acts of the Russian Federation”, which eliminates the possibility of civil, administrative and criminal liability for parallel import of goods.

The Russian Government adopted Regulation No. 947 “On the use of an invention to produce of a medicine in the Russian Federation for its further export without the patentholder consent” on 25 May 2022. The Regulation establishes the procedure for issuing export licenses, as well as the methodology for calculation of the sum of compensation to patentholders.

Decree of the Russian President No. 322 "On the Temporary Procedure of Performance of Obligations to Certain Rights Holders" entered into force on 27 May 2022.